Aktis Oncology
$175.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Aktis Oncology is currently valued at N/A as of September 20, 2024. The company has raised a total of $336.0M in funding.
Investment Perspective
Aktis Oncology's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Aktis Oncology Worth in 2025?
As of 2025, Aktis Oncology is valued at N/A, based on the company's Early Stage VC funding round in September 20, 2024. This valuation positions Aktis Oncology as one of the leading private companies in the sector.
Aktis Oncology Valuation History
Aktis Oncology's funding history demonstrates steady growth and investor confidence.
How Aktis Oncology Valuation is Determined
Private company valuations like Aktis Oncology's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Aktis Oncology Valuation FAQs
Is Aktis Oncology profitable?
Aktis Oncology has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Aktis Oncology's valuation compare to competitors?
Aktis Oncology is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Aktis Oncology IPO?
Aktis Oncology has not announced plans for an initial public offering. Until an IPO, investors can access Aktis Oncology shares through secondary market platforms.